Bellshill, United Kingdom · Founded 2017 · Privately Held (backing)
Developer of microbiome-modulating drugs designed to restore health and prevent bacterial infections. EnteroBiotix is based in Bellshill, United Kingdom and was founded in 2017. Its last reported valuation was $66.8 million in Mar 2024. It has raised $94.2 million across 6 recorded rounds; the latest was a $5.3 million early-stage round in Mar 2026.
Last reported valuation
$66.8M
Oct 2026
Priced at
—
Total raised
$94.2M
Last round
Early Stage VC
Mar 2026
Team — not yet on record
No current team members for EnteroBiotix are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of EnteroBiotix with a free account
·The complete investor list: 20 names
·Watch EnteroBiotix: the Monday email on marks, rounds and moves
